| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.086 | 2.093 | 2.102 | 2.855 | 2.404 | 2.328 | 2.356 | 2.749 | 3.794 | 3.256 |
| Total Income - EUR | 2.086 | 2.093 | 2.102 | 2.855 | 2.404 | 2.328 | 2.506 | 2.749 | 3.794 | 3.256 |
| Total Expenses - EUR | 2.088 | 1.928 | 1.503 | 2.316 | 2.344 | 2.130 | 2.273 | 2.681 | 3.630 | 2.639 |
| Gross Profit/Loss - EUR | -2 | 164 | 598 | 539 | 60 | 198 | 233 | 68 | 163 | 618 |
| Net Profit/Loss - EUR | -65 | 102 | 535 | 453 | -4 | 133 | 151 | -14 | 137 | 471 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Promed Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 61 | 0 | 0 | 93 | 75 | 121 | 96 | 70 | 226 | 696 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 61 | 0 | 0 | 93 | 75 | 121 | 96 | 70 | 226 | 696 |
| Shareholders Funds | -1.515 | -1.398 | -839 | -370 | -368 | -227 | -72 | -86 | 51 | 522 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.577 | 1.398 | 839 | 463 | 443 | 348 | 168 | 157 | 174 | 174 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Promed Impex S.r.l.